Download original image
Fig. 1.
The 100-day survival rate after initiation of combination therapy was 90.9%.
Blood Res 2017;52:167~173
https://doi.org/10.5045/br.2017.52.3.167
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by
INFOrang Co., Ltd